Clinical study for the first relapsed ALL in children. JPLSG ALL-R08-I: Prospective observational study

Clinical study for the first relapsed ALL in children. JPLSG ALL-R08-I: Prospective observational study - Prospective observational study for the relapsed ALL in children: JPLSG ALL-R08-I

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000002026

Enrollment

Registered

2009-06-01

Start date

2009-06-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

first relapsed acute lymphoblastic leukemia in children

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1. first relapsed ALL 2. Be<18 year old at initial diagnosis and be <20 year old at the enrollment 3. Parents(or leagal guardians) must provide signed, written informed consent.

Exclusion criteria

Exclusion criteria: Patients with mature B-ALL, Ph chromosome positive ALL or MLL gene rearrangement positive ALL.

Design outcomes

Primary

Measure	Time frame
3 year-event free survival rate(3y-EFS), 3 year-overall survival rate(3y-OS)	—

Countries

Japan

Contacts

Public ContactAkiko Saito

Japanese Pediatric Leukemia/Lymphoma study Group Data Center

nsgdata@nnh.hosp.go.jp052-951-1111(2751)

Outcome results